$NASDAQ:BIIB

BIOGEN Celebrates FDA Approval of Lecanemab to Treat Early Alzheimer’s Disease

Trending News ☀️ Biogen Inc ($NASDAQ:BIIB) is a global biotechnology company based in Cambridge, Massachusetts that develops and manufactures innovative [...]

By |January 12, 2023|Categories: Drug Manufacturers - General|Tags: , , |0 Comments
Read More

Congressional Inquiry Accuses FDA and Biogen of Improper Collaboration on 2021 Approval of Aduhelm Alzheimer’s Treatment

Trending News ☀️ Biogen Inc ($NASDAQ:BIIB). is an American biotechnology company based in Cambridge, Massachusetts. It is a global leader [...]

By |December 30, 2022|Categories: Drug Manufacturers - General|Tags: , , |0 Comments
Read More

Biogen and Eisai’s Alzheimer’s Treatment Could Cost Up to $30K Per Year, According to Wells Fargo

Trending News ☀️ Biogen Inc ($NASDAQ:BIIB). is a biopharmaceutical company focused on discovering, developing, and delivering innovative therapies to improve [...]

By |December 25, 2022|Categories: Drug Manufacturers - General|Tags: , , |0 Comments
Read More

Biogen Expands Neurosciences Portfolio with Multiple MS Treatments, Immunology Biosimilars, and Breakthrough Alzheimer’s Therapy

Trending News ☀️ Biogen Inc Stock Fair Value – Biogen Inc ($NASDAQ:BIIB). is a multinational biotechnology enterprise headquartered in Cambridge, [...]

By |December 15, 2022|Categories: Intrinsic Value|Tags: , , |0 Comments
Read More

Investing Everyone Can Do.

Investing shouldn’t be exclusive to a select few. We believe everyone should have the opportunity to grow their wealth. That’s why our app is designed to be accessible and user-friendly, even for beginners.

Web App

Support Portal

Go to Top